Document is current
Any future updates will be listed below
-
Authors
Wang, Yiting
Wen, Yan https://orcid.org/0000-0003-4271-3212
Kim, Kayla
Wu, Hugo
Zhang, Jerry
Dobberfuhl, Amy D.
Chen, Bertha
-
Funding
Funding for this research was provided by:
National Institutes of Health (1 R21 HD102224)
California Institute for Regenerative Medicine (TRAN1-10958)
- License Information
-
More Information
Article History
Received: 1 April 2024
Accepted: 26 August 2024
First Online: 11 September 2024
Declarations
:
: This study was approved by (1) the Institutional Review Board of the Stanford University School of Medicine, protocol title “Alteration in the expression of collagen and elastin metabolism-related proteins in pelvic tissues from women with and without pelvic organ dysfunction” (#9992, 02/28/2024-, Regular-continuing review). This protocol includes the ethics approval for consenting participants. All three participants signed the approved consent to participate, (2) the Stanford University Stem Cell Research Oversight Committee, protocol: Derivation of Primary Donor Cell Lines for Human Cell Reprogramming (#40, 02/13/2024-, Renewal), (3) the Stanford University Stem Cell Research Oversight Committee, protocol: Autologous iPSC-derived smooth muscle cell therapy for treatment of urinary incontinence and pelvic floor prolapse (#439, 02/13/2024-, Renewal), and (4) the Institutional Review Board of the Stanford University School of Medicine and Institutional Animal Care and Use Committee (IACUC), protocol: Treatment of stress urinary incontinence and pelvic floor prolapse with skin and vaginal wall fibroblast derived stem cells and stem cell-derived smooth muscle progenitor cells, Approval (#33817, 08/09/2023-, Revision).
: All authors have confirmed their consent for publication.
: The authors declare no conflicts of interest.
